| abstract |
The present invention relates to fused heterocyclic compounds of Formula (la), a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a pharmaceutically acceptable solvate, a polymorph, N-oxide, S-oxide, or a carboxylic acid isostere thereof; processes for their preparation; pharmaceutical compositions comprising said compounds; and their use for the treatment of inflammatory or metabolic diseases mediated by GPR120 receptor. (see formula 1A) |